These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 27256302

  • 21. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Quigley HA.
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [Abstract] [Full Text] [Related]

  • 22. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T.
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [Abstract] [Full Text] [Related]

  • 23. Health literacy and adherence to glaucoma therapy.
    Muir KW, Santiago-Turla C, Stinnett SS, Herndon LW, Allingham RR, Challa P, Lee PP.
    Am J Ophthalmol; 2006 Aug; 142(2):223-6. PubMed ID: 16876500
    [Abstract] [Full Text] [Related]

  • 24. Psychometric properties of the Glaucoma Treatment Compliance Assessment Tool in a multicenter trial.
    Barker GT, Cook PF, Schmiege SJ, Kahook MY, Kammer JA, Mansberger SL.
    Am J Ophthalmol; 2015 Jun; 159(6):1092-1099.e2. PubMed ID: 25794793
    [Abstract] [Full Text] [Related]

  • 25. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA, Mukesh BN, Kitchner TE, Hubbard WC, Wilke RA, Burmester JK, Patchett RB.
    J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
    [Abstract] [Full Text] [Related]

  • 26. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
    Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, Lee PP.
    Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
    [Abstract] [Full Text] [Related]

  • 27. Accounting for restart rates in evaluating persistence with ocular hypotensives.
    Schwartz GF, Platt R, Reardon G, Mychaskiw MA.
    Ophthalmology; 2007 Apr; 114(4):648-52. PubMed ID: 17398318
    [Abstract] [Full Text] [Related]

  • 28. Impact of the introduction of generic latanoprost on glaucoma medication adherence.
    Stein JD, Shekhawat N, Talwar N, Balkrishnan R.
    Ophthalmology; 2015 Apr; 122(4):738-47. PubMed ID: 25680226
    [Abstract] [Full Text] [Related]

  • 29. Glaucoma severity and medication adherence in a county hospital population.
    Ung C, Zhang E, Alfaro T, Murakami Y, Zhang M, Seider MI, Lin SC, Singh K.
    Ophthalmology; 2013 Jun; 120(6):1150-7. PubMed ID: 23453512
    [Abstract] [Full Text] [Related]

  • 30. Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population.
    Zhu Z, Jiang Y, Wang W, Scheetz J, Shang X, Zhang L, He M.
    Clin Exp Ophthalmol; 2019 Sep; 47(7):881-891. PubMed ID: 31034700
    [Abstract] [Full Text] [Related]

  • 31. Hypotensive medication, statins, and the risk of glaucoma.
    Owen CG, Carey IM, Shah S, de Wilde S, Wormald R, Whincup PH, Cook DG.
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3524-30. PubMed ID: 20130286
    [Abstract] [Full Text] [Related]

  • 32. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
    Flowers B, Wand M, Piltz-Seymour J, Berke SJ, Day D, Teague J, Smoot TM, Landry TA, Bergamini MV, Mallick S, Travatan Dosing Aid Study Group.
    Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
    [Abstract] [Full Text] [Related]

  • 33. The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003.
    Owen CG, Carey IM, De Wilde S, Whincup PH, Wormald R, Cook DG.
    Br J Ophthalmol; 2006 Jul; 90(7):861-8. PubMed ID: 16782949
    [Abstract] [Full Text] [Related]

  • 34. Use of glaucoma medications: state of the science and directions for observational research.
    Lu VH, Goldberg I, Lu CY.
    Am J Ophthalmol; 2010 Oct; 150(4):569-574.e9. PubMed ID: 20678750
    [Abstract] [Full Text] [Related]

  • 35. Impact of a Brief Educational Intervention on Glaucoma Persistence: A Randomized Controlled Clinical Trial.
    Djafari F, Lesk MR, Giguère CÉ, Siam G, Freeman EE.
    Ophthalmic Epidemiol; 2015 Oct; 22(6):380-6. PubMed ID: 26653260
    [Abstract] [Full Text] [Related]

  • 36. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF, Hubatsch DA, Amaris P.
    BMC Ophthalmol; 2015 Nov 12; 15():166. PubMed ID: 26563363
    [Abstract] [Full Text] [Related]

  • 37. Determinants of adherence to glaucoma medical therapy in a long-term patient population.
    Djafari F, Lesk MR, Harasymowycz PJ, Desjardins D, Lachaine J.
    J Glaucoma; 2009 Mar 12; 18(3):238-43. PubMed ID: 19295380
    [Abstract] [Full Text] [Related]

  • 38. Variations in treatment among adult-onset open-angle glaucoma patients.
    Friedman DS, Nordstrom B, Mozaffari E, Quigley HA.
    Ophthalmology; 2005 Sep 12; 112(9):1494-9. PubMed ID: 16019072
    [Abstract] [Full Text] [Related]

  • 39. The relationship between sociodemographic factors and persistence with topical glaucoma medications.
    Leung VC, Jin YP, Hatch W, Mammo Z, Trope GE, Buys YM, Macrae WG.
    J Glaucoma; 2015 Jan 12; 24(1):69-76. PubMed ID: 25055210
    [Abstract] [Full Text] [Related]

  • 40. Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.
    Ritchey M, Tsipas S, Loustalot F, Wozniak G.
    PLoS One; 2016 Jan 12; 11(7):e0159366. PubMed ID: 27428008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.